Search results

Last week, the CDC released the results of a study that enumerates “Ten Great Public Health Achievements” in the U.S. from 2001 to 2010. Among other triumphs, the report notes a substantial decline in vaccine-preventable diseases and strides made in the prevention of cardiovascular disease, cancer and childhood lead poisoning.

Ladies and gentleman, boys and girls: there are obesity updates for all. For all the kids out there, the Institute of Medicine (IOM) released a new report Wednesday offering early childhood obesity prevention advice for daycare centers and households alike.

In other weight loss news, one of the authors of a new study recommends that weight loss surgeries, such as gastric bypass and gastric banding, become front line type 2 diabetes treatments.

A bipartisan bill introduced to Congress by Georgia Republican Phil Gingrey the Generating Antibiotics Incentives Now (GAIN) Act attempts to spur interest among pharmaceutical companies to develop new and effective antibiotics, traditionally an unprofitable sector of the drug market. The new bill hopes to change all that by creating certain incentives.

Age-related macular degeneration (AMD) affects approximately 6.5 percent of Americans ages 40 and older and is the leading cause of vision loss among those over 55. Treating the condition is often difficult, but a new prospective study published in the Archives of Ophthalmology offers some hope that diets rich in certain antioxidants, zinc, and omega-3 fatty acids may help prevent early AMD in patients who have a high genetic risk for the disease.

On the eastern front, we have yet another example of Mayor Bloomberg s overreaching food bans this time, he s targeting vending machines and concession stands in municipal buildings. His health police gave orders this week to nine vendors, stipulating that they have six months to ensure that beverages containing over 25 calories per eight-ounce serving occupy no more than two slots on any vending machine.

The Safe Cosmetics Act, now in a 2011 edition, is back in Congress and its claims about cosmetics ingredient safety are about as superficial as the pro

Should the cancer drug Avastin be approved as a treatment for metastatic breast cancer? The FDA has been considering this question since the emotionally charged debate began last December, when the agency first proposed revoking the drug s indication for that use. As expected, on Wednesday, an FDA advisory panel voted unanimously to recommend the revocation, citing follow-up studies by the manufacturer, Roche, that showed that the drug did not significantly increase survival time.

Quick, run for cover: junk food ads are out to get your children and make them fat. Or at least that s what the American Academy of Pediatrics (AAP) is now preaching. As described in a new policy statement published in the journal Pediatrics, the AAP s Dr. Victor Strasburger asserted, It s time for the food industry to clean up its act and not advertise junk food to young children.

ACSH has been skeptical about the recent move by various school districts (about 30 percent nationwide since 2006) to reduce the toll of childhood obesity by sending overweight or obese children home with letters reporting their body-mass index (BMI), which is a crude measure of weight relative to height.

Anyone who s had chicken pox (varicella zoster, a member of the herpes family of viruses) has a one-in-three chance of developing shingles many years later, and the risk only increases with age. Yet although the FDA approved a vaccine (Zostavax) for the virus in 2006 and, this March, approved its use for those age 50 and over, very few at-risk adults have been vaccinated. Adults over 60 are most vulnerable to shingles, but in 2009, only 10 percent of this population was vaccinated.

Pfizer s smoking cessation drug Chantix continues to be problematic since its 2006 appearance in U.S. pharmacies. The prescription drug, which works by blocking nicotine receptors, has already been associated with psychiatric side effects and it now appears to lead to some cardiovascular problems in patients who have a history of heart disease.

The Supreme Court handed down a decision yesterday that represents a significant victory for the pharmaceutical industry. The court s 5-to-4 ruling shields generic drug makers from failure-to-warn lawsuits as long as their product labels are identical to those of brand-name manufacturers. Generic pharmaceutical companies Teva Pharmaceutical Industries, Mylan Inc.

In Tuesday s Wall Street Journal, Melinda Beck investigates the efficacy of the ubiquitous multivitamin. What she uncovers, in fact, is that the majority of us don t need one at all. Beck points to a 2007 National Institutes of Health (NIH) panel, which concluded that the present evidence is insufficient to recommend either for or against the use of [multivitamins and minerals] by the American public to prevent chronic disease.

The results of a new study should provide ample relief for coffee-loving women who are worried about heart disease.

A study just published in Clinical Cancer Research has confirmed that treating HER2-positive metastatic breast cancer with the drug trastuzumab (Herceptin) is as effective as chemotherapy or surgery. Of particular interest is that the drug can treat metastases involving the brain, often a problem with chemotherapy, since many drugs cannot penetrate the blood-brain barrier.

Tuberculosis (TB) test-kit manufacturers were castigated by the World Health Organization (WHO) yesterday, while their sales in developing countries were placed under immediate ban due to unacceptable levels of wrong results and perverse financial incentives to boost sales, according to a WHO statement.

Speaking of how the media is prone to broadcasting flawed observational studies, an article in yesterday s The New York Times reports on research claiming that eating even a little daily meat may increase a person s risk of Type 2 diabetes.

In yesterday s Huffington Post, Sen. Kirsten Gillibrand (D-NY) writes how she was shocked to learn that regulators have been prevented from testing all of the 70,000 chemicals found in everyday home products.

Generic drugs should be manufactured to look exactly like their name brand counterparts, write Dr. Jeremy Greene and Dr. Aaron Kesselheim in an editorial for the New England Journal of Medicine. But under a current federal regulation known as trade dress, generics cannot be produced to resemble branded medications already on the market.

The findings of the newest study on the link between childhood brain cancer and cell phone use will be a dropped call to those convinced that heavy cell phone users are a few minutes away from developing cancer.

It would seem that the chest pain many patients fear to be a heart attack in the making does not accurately predict one s risk of having acute coronary syndrome or a heart attack (acute myocardial infarction, AMI), says a new study published in the Annals of Emergency Medicine.

The medical community has gradually become aware of a difference between the care that black and white women with invasive breast cancer receive. It had been typically assumed that the discrepancy was due largely to reduced access to care. Now, however, a new study shows that, even when both groups have equal access to health care, the disparity remains.

A study from the Georgetown School of Medicine confirms what most of us already know: so-called colon cleansing is not only worthless, but can be dangerous as well. Also called colonic hydrotherapy, the procedure consists of inserting a tube into the rectum and flushing the large intestine with volumes of water that may or may not be mixed with various chemicals, including laxatives.